Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LSAMP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMCX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01234 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MEIOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KIAA1671 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK5RAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00557 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BGLT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR142 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRCP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on